Research graph
References from Longitudinal plasma and urinary SP-D and sRAGE during BEP chemotherapy in germ cell tumours. Local targets link to admitted publications; unresolved targets remain external evidence.
Pulmonary function in patients with germ cell cancer treated with bleomycin, etoposide, and cisplatin
10.1200/jco.2015.64.8451 · 2016 · External reference
Bleomycin lung toxicity: who are the patients with increased risk
10.1016/j.pupt.2005.01.007 · 2005 · External reference
Predicting the risk of bleomycin lung toxicity in patients with germ-cell tumours
10.1093/annonc/mdg020 · 2003 · External reference
Bleomycin-induced lung injury
10.1155/2013/480608 · 2013 · External reference
Biomarkers of lung damage with possible predictiveness of ARDS within CS in super high-risk patients with germ cell tumors
10.1200/jco.2020.38.6_suppl.411 · 2020 · External reference
Toxicity of BEP chemotherapy in germ cell tumors: Focus on immune-mediated bleomycin pulmonary toxicity in comparison with EP and VIP regimens
10.3389/fimmu.2026.1861834 · 2026 · External reference
Surfactant protein D is a useful biomarker for monitoring acute lung injury in rats
10.1080/01902148.2016.1215570 · 2016 · External reference
Pulmonary surfactant protein D in sera and bronchoalveolar lavage fluids
10.1164/ajrccm.152.6.8520747 · 1995 · External reference
Plasma surfactant protein levels and clinical outcomes in patients with acute lung injury
10.1136/thorax.58.11.983 · 2003 · External reference
Plasma sRAGE is independently associated with increased mortality in ARDS: a meta-analysis of individual patient data
10.1007/s00134-018-5327-1 · 2018 · External reference
Soluble receptor for advanced glycation end-products predicts impaired alveolar fluid clearance in acute respiratory distress syndrome
10.1164/rccm.201501-0020oc · 2015 · External reference
Radical roles for RAGE in the pathogenesis of oxidative stress in cardiovascular diseases and beyond
10.3390/ijms141019891 · 2013 · External reference
Development of a best-practice clinical guideline for the use of bleomycin in the treatment of germ cell tumours in the UK
10.1038/s41416-018-0300-x · 2018 · External reference
Systemic immune-inflammation index in germ-cell tumours: search for a biological prognostic biomarker
10.1038/bjc.2017.460 · 2018 · External reference
Reporting recommendations for tumor marker prognostic studies (REMARK)
10.1093/jnci/dji237 · 2005 · External reference
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
10.1016/s0140-6736(07)61602-x · 2007 · External reference
The effect of pulmonary function testing on bleomycin dosing in germ cell tumours
10.1111/imj.13158 · 2016 · External reference
